Diagnosis and Management of Drug-Induced Liver Injury training course - Paris, France

Brand New DIA Training Course DIA Europe is proud to announce a recent addition to the training course portfolio: Diagnosis and Management of Drug-Induced Liver Injury (DILI) 19-20 September 2013 | Paris, France This brand new DIA training course is entirely dedicated to Drug-Induced Liver Injury (DILI) and led by a Hepatologist with extensive experience in clinical assessment of DILI, who published ‘RUCAM’ the widely used causality assessment method of DILI.   The medical approach presented in this training course is also based on the conclusions of international consensus meetings on adverse drug reactions and guidelines published by regulatory authorities. Training Course Calendar 2013 DIA’s highly rated instructor-led training courses are designed to inform and educate professionals and experts on critical issues related to pharmaceuticals, biotechnology, and medical products. Courses on more than 50 topics provide professionals from industry, government, and academia with the opportunity to exchange ideas, knowledge, and best practices with peers and expert instructors. Courses offered range from European regulatory affairs to drug development to safety inspection preparation. View the overview of courses on offer in 2013.

Email Preferences | My DIA | Forward to a Friend |

4th Pharmacovigilance Conference in Bangalore March 8-9

Register Today! The date of the 4th Pharmacovigilance Conference in India is fast approaching. Take this opportunity to discuss the latest global challenges in drug safety with professionals worldwide. Professionals attending the two-day conference, to be held in Bangalore from March 8-9, will learn about current global safety reporting requirements for prescription and over-the-counter drugs and discuss new, pragmatic approaches to pharmacovigilance. Other key topics will include the regulatory agency clinical safety and pharmacovigilance inspection program in the US, Europe, and Japan, and identifying best practices for quality assurance in post-marketing pharmacovigilance and clinical safety. Read More View Program Register EXHIBITING OPPORTUNITY Download the application for a tabletop display at the event. Other events of Interest Download the India Calendar of Events Conference Highlights Updates on recently released GPvP Modules by EMA Japanese model of EPPV – a way forward for other Asian countries Challenges in authoring PSUR for generic manufacturers An insight into Drug Induced Liver Injury (DILI) Global regulatory compliance: challenges and the way forward Safety regulations in emerging Middle East region Efficient management of literature searching Enhanced productivity and quality through process re-engineering; case studies Global outsourcing trends in PV – Indian potential and challenges by China, Taiwan, and Latin America RSI management – best practices to safeguard against pitfalls Attrition and manpower stability; KPO perspective Technology-watch against safety hazard of spurious and adulterated drugs Training; A Formality or a Reality – an industry insight Panel discussion: compensation for trial related injuries This Pharmacovigilance Conference is perfect for professionals with experience in clinical safety and who are involved in: Pharmacovigilance Clinical research Risk management Compliance Medical information Regulatory affairs Academia Pharmacology Read More View Program Register To know more, contact Manoj.Trivedi@diaindia.org Thank You to our Media Partner

Email Preferences | My DIA | Forward to a Friend |

New Insights into Current PV Challenges - March 8-9, 2013 Bangalore

Read more about the speakers and hot topics Check out the program for the 4th Pharmacovigilance Conference in India to find out more about this insightful event focusing on the latest global challenges in drug safety. Professionals attending this two-day conference, to be held in Bangalore from March 8-9, will learn about current global safety reporting requirements for prescription and over-the-counter drugs and discuss new, pragmatic approaches to pharmacovigilance. Other key topics will include the regulatory agency clinical safety and pharmacovigilance inspection program in the US, Europe, and Japan, and identifying best practices for quality assurance in post-marketing pharmacovigilance and clinical safety. Read More View Program Register EXHIBITING OPPORTUNITY Download the application for a tabletop display at the event. Other events of Interest Download the India Calendar of Events Conference Highlights Updates on recently released GPvP Modules by EMA Japanese model of EPPV – a way forward for other Asian countries Challenges in authoring PSUR for generic manufacturers An insight into Drug Induced Liver Injury (DILI) Global regulatory compliance: challenges and the way forward Safety regulations in emerging Middle East region Efficient management of literature searching Enhanced productivity and quality through process re-engineering; case studies Global outsourcing trends in PV – Indian potential and challenges by China, Taiwan, and Latin America RSI management – best practices to safeguard against pitfalls Attrition and manpower stability; KPO perspective Technology-watch against safety hazard of spurious and adulterated drugs Training; A Formality or a Reality – an industry insight Panel discussion: compensation for trial related injuries This Pharmacovigilance Conference is perfect for professionals with experience in clinical safety and who are involved in: Pharmacovigilance Clinical research Risk management Compliance Medical information Regulatory affairs Academia Pharmacology So make sure you save the date in your calendar for the 4th Pharmacovigilance Conference. Read More View Program Register To know more, contact Manoj.Trivedi@diaindia.org Thank You to our Media Partner

Email Preferences | My DIA | Forward to a Friend |